Tim Scott actually said...

I come back to the Cures Act because I think that there is a lot of opportunity for that to be a template for policymaking in this regard.

I would appreciate you expounding on that because there has been much conversation around the pricing.

I know that in many ways, the African American community does not necessarily participate at high rates in drug testing.

I applaud the commitment to patient-focused drug development in PDUFA V.